EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.11.14 | Ala-4-nitroanilide + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.11.14 | Aplysia insulin D + H2O |
Aplysia insulin D degrades slowly under the effects of mAAP |
Sus scrofa |
? |
- |
? |
3.4.11.14 | Arg-Arg-7-amido-4-methylcoumarin |
13% of the activity with Ala-7-amido-4-methylcoumarin |
Rattus norvegicus |
? |
- |
? |
3.4.11.14 | CKKQ20KK + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.11.14 | KKE-(5-[(2-aminoethyl) amino]-naphthalene-1-sulfonic acid)-Q9K-((4'-dimethylaminoazobenzene-4'-sulfonyl))-K + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.11.14 | KKQ30KK + H2O |
- |
Homo sapiens |
? |
- |
? |
3.4.11.14 | Lys-Ala-7-amido-4-methylcoumarin |
79% of the activity with Ala-7-amido-4-methylcoumarin |
Rattus norvegicus |
? |
- |
? |
3.4.11.14 | Met-enkephalin + H2O |
- |
Rattus norvegicus |
? |
releases only the N-terminal tyrosine |
? |
3.4.11.14 | more |
there are two active centre ionizable groups with pKa values of approximately 6.0 and 7.5 which are involved in substrate binding or inhibitory amino acid binding |
Homo sapiens |
? |
- |
? |
3.4.11.14 | more |
no activity with: Gly-Pro-7-amido-4-methylcoumarin, butyloxycarbonyl-Phe-Ser-Arg-7-amido-4-methylcoumarin, butyloxycarbonyl-Gln-Ala-Arg-7-amido-4-methylcoumarin, butyloxycarbonyl-ValยPro-Arg-7-amido-4-methylcoumarin,succinyl-Ala-Ala-Ala-7-amido-4-methylcoumarin, succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin, succinyl-Gly-Pro-7-amido-4-methylcoumarin, succinyl-Gly-Pro-Leu-Gly-Pro-7-amido-4-methylcoumarin, succinyl-Ile-Ile-Trp-7-amido-4-methylcoumarin, benzyloxycarbonyl-Phe-Arg-7-amido-4-methylcoumarin, acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin |
Rattus norvegicus |
? |
- |
? |